Did Hedge Funds Catch A Break With BioMarin Pharmaceutical Inc. (BMRN)?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Posts Tagged ‘NASDAQ:BMRN’
10 Jim Cramer Stocks to Buy in Q1 2022
In this article, we discuss the 10 Jim Cramer stocks to buy in Q1 2022.
Is BioMarin Pharmaceutical Inc. (BMRN) A Good Stock To Buy?
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy...
10 Healthcare and Software Stocks to Buy According to Michel Massoud’s Melqart Asset Management
In this article, we take a look at the 10 healthcare and software stocks to buy according to Michel Massoud’s Melqart Asset Management.
5 Biotech and Pharmaceutical Stocks to Buy According to Palo Alto Investors
In this article, we will discuss 5 biotech and pharmaceutical stocks to buy according to Palo Alto Investors based on Q2 holdings of the fund.
5 Best Genomic Stocks to Buy Now
In this article, we will take a look at the 5 best genomic stocks to buy now.
Hedge Funds Are Nibbling On BioMarin Pharmaceutical Inc. (BMRN)
A whopping number of 13F filings filed with U.S.
10 Stocks Stanley Druckenmiller is Selling
In this article, we discuss the 10 stocks Stanley Druckenmiller is selling.
Is BioMarin Pharmaceutical Inc. (BMRN) A Good Stock To Buy?
Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips or bumps on the charts usually don't make them change...
Here’s Why ClearBridge Sold its BioMarin Pharmaceutical (BMRN) Position
ClearBridge Investments, an investment management firm, published its “SMID Cap Growth Strategy” first quarter 2021 investor letter – a copy of which can be downloaded here...
Is BioMarin (BMRN) Stock A Buy or Sell?
In this article we will take a look at whether hedge funds think BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is a good investment right now.
Is BioMarin Pharmaceutical (BMRN) Stock a Buy For 2021?
Carillon Eagle Mid Cap Growth Fund recently released its Q3 2020 Investor Letter, a copy of which you can download here.
Is BioMarin Pharmaceutical (BMRN) a Smart Long-term Buy?
Alger Spectra Fund recently released its Q3 2020 Investor Letter, a copy of which you can download here.
Is BMRN A Good Stock To Buy Now?
Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed out as the stock market...
Were Hedge Funds Right About Souring On BioMarin Pharmaceutical Inc. (BMRN)?
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Should I Avoid BioMarin Pharmaceutical Inc. (BMRN)?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Hedge Fund and Insider Trading News: Steven A Cohen, Crispin Odey, Ray Dalio, Warren Buffett, Adrigo Hedge, iMedia Brands Inc (IMBI), Estee Lauder Companies Inc (EL), and More
The $400 billion corner of quant investing known as risk parity has a history of doubt and division, and Bridgewater Associates has started a new chapter.
Were Hedge Funds Right About Piling Into BioMarin Pharmaceutical Inc. (BMRN)?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Hedge Funds Have Never Been More Bullish On BioMarin Pharmaceutical Inc. (BMRN)
In this article we will take a look at whether hedge funds think BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is a good investment right now.
Is BioMarin Pharmaceutical Inc. (BMRN) Going to Burn These Hedge Funds?
Coronavirus is probably the #1 concern in investors' minds right now. It should be.
BioMarin Pharmaceutical Inc. (BMRN) vs. Hedge Fund Favorites in 2019
Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals.
BioMarin Pharmaceutical Inc. (BMRN): Hedge Funds In Wait-and-See Mode
The 700+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the third quarter, which unveil their equity...
BioMarin Pharmaceutical Inc. (BMRN): Hedge Funds Fumbled the Ball
Does BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) represent a good buying opportunity at the moment? Let’s quickly check the hedge fund interest towards the company.
Here is What Hedge Funds Think About BioMarin Pharmaceutical Inc. (BMRN)
Before we spend countless hours researching a company, we'd like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Were Hedge Funds Right About BioMarin Pharmaceutical Inc. (BMRN) ?
World-class money managers like Ken Griffin and Barry Rosenstein only invest their wealthy clients' money after undertaking a rigorous examination of any potential stock.
Argentiere Capital’s Returns, AUM and Holdings
Deepak Gulati's Argentiere Capital is a Zug, Switzerland-based hedge fund launched back in June 2013, with an additional office in Chicago.
Here is What Hedge Funds Think About BioMarin Pharmaceutical Inc. (BMRN)
The 700+ hedge funds and money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the second quarter, which unveil their equity positions...
Hedge Funds Are Buying BioMarin Pharmaceutical Inc. (BMRN)
Out of thousands of stocks that are currently traded on the market, it is difficult to determine those that can really generate strong returns.
Palo Alto Investors’s Bets on ABIOMED, Inc. (ABMD), United Therapeutics Corporation (UTHR) and Other Stocks Lift Its Q3 Returns
Palo Alto Investors was founded by William Leland Edwards in 1989. The fund usually invests in companies with market capitalization less than $3 billion.
Catalyst Pharmaceuticals Inc (CPRX) Isn’t Out Of The Woods With Firdapse Just Yet
Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) just announced that it is carrying forward with a special protocol assessment (SPA) for its lead asset, Firdapse, for the treatment ...
10 Most Successful Innovative Companies in The World in 2016
Bringing something new to the table is something that seems to be difficult these days, considering that many things have already been done, have already been invented, and have...
A Look At The Science Behind BioMarin Pharmaceutical Inc. (BMRN)’s Next Pivotal Candidate
BioMarin Pharmaceutical Inc.
Blue Jay Capital Betting On Big Returns From These Healthcare Stocks
Founded by Paul Sinclair in August 2014, Blue Jay Capital Management is a healthcare-focused hedge fund based in California.
BioMarin Pharmaceutical Inc. (BMRN)’s Setback Isn’t Really A Setback
BioMarin Pharmaceutical Inc.
Thursday’s Top Trending Tickers: MSFT, VOD, LB, BMRN, GLW
The U.S stock market is green across the board as positive reigns ahead of crucial jobs data to be announced tomorrow.
Why Traders Are Buzzing About MGM, Apple, and Three Other Companies Today
Although crude futures are well in the green, the three indexes have opened in the red on Friday. The Dow and S&P 500 are off by 0.2% while the NASDAQ index has lost around 0...
Mariner Investment’s Top Healthcare Picks
Among some 800 hedge funds we track at Insider Monkey, we seldom come across funds that specialize in investing in a particular sector or have a penchant for investing in companies...
Palo Alto’s Top Picks for This Year Following Impressive 2015 Returns
William Leland Edwards' Palo Alto Investors has about $2.22 billion worth of regulatory assets under its management.
Top Stock Picks of Multi-Billion Dollar, Healthcare-Focused Fund Palo Alto Investors
Palo Alto Investors, founded by Wall Street veteran William Leland Edwards in 1989, is one of the biggest healthcare investment shops in the United States, with over $2 billion...
New Additions Highlight Kyle Bass’ Top Stock Picks for Q4
Kyle Bass of Hayman Advisors is one investment manager with great cachet, which includes having a chapter dedicated to him in Michael Lewis' post 2007-08 financial crises book...
Is BioMarin Pharmaceutical Inc. (BMRN) A Good Stock To Buy?
Between June 25 and October 30th the Russell 2000 ETF (IWM) lagged the larger S&P 500 ETF (SPY) by more than 14 percentage points as investors worried over the possible ramifications...
BioMarin Pharmaceutical Inc. (BMRN) Surges But Is It A Good Stock To Buy Now?
Is BioMarin Pharmaceutical Inc.
Endo International plc (ENDP), BioMarin Pharmaceutical Inc. (BMRN): Visium Picks Returned 13% but Net Returns Were Only 5% – Here’s Why
The broad portfolio of Jacob Gottlieb’s Visium Asset Management enjoyed a very strong quarter, with the weighted average returns of its 817 reported positions in companies with...
Billionaire John Griffin’s Five Picks That Killed the Market This Quarter
John Griffin’s Blue Ridge Capital had a great start to the year, as its 45 long positions in stocks with a market cap above $1.0 billion returned 6.8% in the first quarter.
Era Group Inc (ERA), BioMarin Pharmaceutical Inc. (BMRN), & Assured Guaranty Ltd. (AGO) Among Stocks Amici Capital Is Bullish on
Paul Orlin's Amici Capital has increased its exposure to Era Group Inc (NYSE:ERA), as a new filing with the Securities and Exchange Commission shows.
Palo Alto Rejoicing at ABIOMED, Inc. (ABMD)’s 18% Spike
ABIOMED, Inc. (NASDAQ:ABMD) spiked as high as 21% in Tuesday's intraday trading to eventually close at 18% in the green at $72.48.
BioMarin Pharmaceutical Inc. (BMRN) and Other Top New Picks of Healthcare-Focused Visium Asset Management
Jacob Gottlieb's Visium Asset Management has recently revealed its equity positions as of the end of the fourth quarter in a 13F filing with the Securities and Exchange Commission...
Tang Capital Management Discloses Moves into La Jolla Pharmaceutical Company (LJPCD), Vanda Pharmaceuticals Inc. (VNDA), Mirati Therapeutics Inc. (MRTX) & Others
Tang Capital Management, led by Kevin C. Tang, revealed in a filing several moves that have impacted its equity portfolio.
Hedge Fund Bets On Onyx Pharmaceuticals, Inc. (ONXX)
As fast as we can type this, Phill Gross and Robert Atchinson's hedge fund, Adage Capital Partners, disclosed ownership of about 3.7 million shares of Onyx Pharmaceuticals, ...
Should You Buy Regeneron Pharmaceuticals Inc (REGN)?
If you were to ask many investors, hedge funds are viewed as delayed, outdated investment vehicles of an era lost to time.
